Rubius Therapeutics OverviewRubius Therapeutics Other Income Expense Net
Other Income/Expense Net for RUBY.
Quarterly Other Income/Expense
-$20.01M
↓ 1446.6% YoY
As of Dec 31, 2022
Annual Other Income/Expense (TTM)
-$24.19M
↓ 974.83% YoY
Trailing 12 months ending Dec 31, 2022